157 related articles for article (PubMed ID: 25681377)
1. Editorial Commentary: Elevated Aminotransferase Levels Among HIV-Infected Persons: What's Lurking Under the Surface?
Crum-Cianflone NF
Clin Infect Dis; 2015 May; 60(10):1579-81. PubMed ID: 25681377
[No Abstract] [Full Text] [Related]
2. Nonalcoholic Steatohepatitis and Hepatic Fibrosis in HIV-1-Monoinfected Adults With Elevated Aminotransferase Levels on Antiretroviral Therapy.
Morse CG; McLaughlin M; Matthews L; Proschan M; Thomas F; Gharib AM; Abu-Asab M; Orenstein A; Engle RE; Hu X; Lempicki R; Hadigan C; Kleiner DE; Heller T; Kovacs JA
Clin Infect Dis; 2015 May; 60(10):1569-78. PubMed ID: 25681381
[TBL] [Abstract][Full Text] [Related]
3. Non-Alcoholic Fatty Liver Disease in Patients with HIV Infection.
Papagianni M; Tziomalos K
AIDS Rev; 2018; 20(3):171-173. PubMed ID: 30264828
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV monoinfected patients.
Vuille-Lessard É; Lebouché B; Lennox L; Routy JP; Costiniuk CT; Pexos C; Giannakis A; Szabo J; Klein MB; Sebastiani G
AIDS; 2016 Nov; 30(17):2635-2643. PubMed ID: 27603289
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of elevated liver transaminases in HIV-infected patients.
Cai J; Osikowicz M; Sebastiani G
AIDS; 2019 Jul; 33(8):1267-1282. PubMed ID: 31008799
[TBL] [Abstract][Full Text] [Related]
6. Liver tolerance of raltegravir-containing antiretroviral therapy in HIV-infected patients with chronic hepatitis C.
Macías J; Neukam K; Portilla J; Iribarren JA; de Los Santos I; Rivero A; Márquez M; Delgado M; Téllez F; Merino D; Giner L; von Wichmann MA; Pineda JA;
J Antimicrob Chemother; 2011 Jun; 66(6):1346-50. PubMed ID: 21398295
[TBL] [Abstract][Full Text] [Related]
7. The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection.
Mehta SH; Thomas DL; Torbenson M; Brinkley S; Mirel L; Chaisson RE; Moore RD; Sulkowski MS
Hepatology; 2005 Jan; 41(1):123-31. PubMed ID: 15619237
[TBL] [Abstract][Full Text] [Related]
8. Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses.
Neuman MG; Monteiro M; Rehm J
Subst Use Misuse; 2006; 41(10-12):1395-463. PubMed ID: 17002989
[TBL] [Abstract][Full Text] [Related]
9. [Use of antiretroviral agents in cirrhotic patients infected by HIV].
Salmon-Céron D
Med Mal Infect; 2004 Nov; 34 Spec No 2():14-9. PubMed ID: 15801534
[No Abstract] [Full Text] [Related]
10. HIV and liver disease.
Navarro J
AIDS Rev; 2022; 25(2):87-96. PubMed ID: 35901073
[TBL] [Abstract][Full Text] [Related]
11. Liver fibrosis in HIV-infected individuals on long-term antiretroviral therapy: associated with immune activation, immunodeficiency and prior use of didanosine.
Kooij KW; Wit FW; van Zoest RA; Schouten J; Kootstra NA; van Vugt M; Prins M; Reiss P; van der Valk M;
AIDS; 2016 Jul; 30(11):1771-80. PubMed ID: 27088320
[TBL] [Abstract][Full Text] [Related]
12. Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV.
Rockstroh JK
Curr HIV/AIDS Rep; 2017 Apr; 14(2):47-53. PubMed ID: 28284005
[TBL] [Abstract][Full Text] [Related]
13. Risks and benefits of using antiretroviral therapy in HIV-infected patients with chronic hepatitis B in developing regions.
Soriano V; Rivas P; Nuñez M
Clin Infect Dis; 2008 Dec; 47(11):1486-9. PubMed ID: 18937578
[No Abstract] [Full Text] [Related]
14. Liver fibrosis after antiretroviral therapy in a longitudinal cohort of sexually infected HIV patients in eastern China.
Wei Q; Lin H; Ding Y; Liu X; Wu Q; Shen W; Gao M; He N
Biosci Trends; 2017 Jul; 11(3):274-281. PubMed ID: 28484111
[TBL] [Abstract][Full Text] [Related]
15. Short Communication: HIV RNA Levels Predict AIDS-Defining and Non-AIDS-Defining Cancers After Antiretroviral Therapy Initiation Among HIV-Infected Adults.
Crum-Cianflone NF; Wang X; Ganesan A; Okulicz J; Weintrob A; Lalani T; Agan B
AIDS Res Hum Retroviruses; 2015 May; 31(5):514-8. PubMed ID: 25417712
[TBL] [Abstract][Full Text] [Related]
16. Decreasing incidence of herpes zoster in the highly active antiretroviral therapy era.
Moanna A; Rimland D
Clin Infect Dis; 2013 Jul; 57(1):122-5. PubMed ID: 23487391
[TBL] [Abstract][Full Text] [Related]
17. Incidence of liver cirrhosis in HIV-infected patients with chronic hepatitis B or C in the era of highly active antiretroviral therapy.
Tuma P; Medrano J; Resino S; Vispo E; Madejón A; Sánchez-Piedra C; Rivas P; Labarga P; Martín-Carbonero L; Barreiro P; Soriano V
Antivir Ther; 2010; 15(6):881-6. PubMed ID: 20834100
[TBL] [Abstract][Full Text] [Related]
18. Castlemans disease in HIV infected patient from eastern India.
Modak D; Ganguly RR; Haldar SN; Samanta PS; Pramanik N; Guha SK
J Assoc Physicians India; 2008 Jul; 56():547-8. PubMed ID: 18846911
[TBL] [Abstract][Full Text] [Related]
19. Short Sleep Duration Is Associated With Abnormal Serum Aminotransferase Activities and Nonalcoholic Fatty Liver Disease.
Kim D; Kim HJ; Kushida CA; Heo NY; Ahmed A; Kim WR
Clin Gastroenterol Hepatol; 2018 Apr; 16(4):588-590. PubMed ID: 28882688
[No Abstract] [Full Text] [Related]
20. Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C.
Macías J; Mira JA; López-Cortés LF; Santos I; Girón-González JA; González-Serrano M; Merino D; Hernández-Quero J; Rivero A; Merchante N; Trastoy M; Carrillo-Gómez R; Arizcorreta-Yarza A; Gómez-Mateos J; Pineda JA
Antivir Ther; 2006; 11(7):839-46. PubMed ID: 17302246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
